Rivulet Media Inc (fka RIVU)

[PG]

Thank you very much for the kudos.

You summed that up succinctly and with admirable authority.

Further, the shares were not issued to repay for monies that Koos has taken from the company that he then loaned the company. On the contrary--the shares issued were to repay Koos for out-of-pocket expenses. Expenses that far surpass $120,000 as a matter of fact and was personal money. Money that he acquired from other endeavors, unrelated to BMSN. Any personal assets that Koos has gained since the inception of BMSN have not been paid for with shareholder money. The issued shares is a very positive sign IMHO due to the fact that I believe that Koos very much believes in this company and the future it holds. I believe he understands full well the economic promise and therefore believes the stock will rise to such that he will profit handsomely, finally, from his personal and professional investment. As will his shareholders.

It should be noted too that Koos probably has the lowest pay of any CEO in San Diego presently as he accepts the bare minimum monthly as pay. The SEC has all of the documentation to attest to this (the lowest in San Diego is my opinion and subject to debate I do understand).

And to broach something that Seldomehome posted--it is my humble opinion that a CUSIP change could very much happen as certain evidence points to the illegal shorting of the stock by corrupt finance companies with which Koos/BMSN has done business with (silly him. But, trial and error, folk. Trial & error). As far as I can determine, each contract made between he and these finance companies clearly stipulates that shorting of the stock used to satisfy the loans is strictly prohibited. I am no corporate lawyer, but, I have been advised by a couple in-the-know that if pursued, in a court of law, these contracts would be considered null & void if Koos can prove the shorting by these entities. Ergo, if he applies for a change of the CUSIP based on this suspicion, such should be granted.

Of course, it is difficult to prove the shorting by the aforementioned. But, not impossible. And let us not speculate on when this might happen as that will only create more of a frenzy among those that do not quite understand how the process works further adding to the spoils so enjoyed by the sharks.

To date, I have found nothing to indicate that the FDA approval for Hema I is anything but very much in our near future. The preclinical trials for the Min Science is going as anticipated. We should be afforded an FDA application for this, too, in the very near future.

BMSN